Our Services

Highlights:

  • Team of eight doctors including haematologists, haemato-oncologists and stem cell transplant team.
  • Completed over 800 bone marrow transplants.
  • 22-bedded transplant unit
  • Outcomes driven by global protocols (10 percent mortality).
  • One of the largest centres for multiple sclerosis, sickle cell and aplastic anaemia treatment
  • Global standard of infection control practises
  • One of the few centres performing matched unrelated donor transplant for thalassemia
  • 40 percent long term outcome data for haploidentical transplant
  • Already treating patients from 18 different countries - first Indian hospital to do a BMT transplant from Trinidad & Tobago

The Department of Haematology, Paediatric Haemoto-oncology & Bone Marrow Transplantation at Fortis Memorial Research Institute (FMRI) provides broad-ranging, integrated and patient-centric services for the diagnosis and management of all kinds of blood disorders in adults and children, including cancers of the blood.

Backed by an extensive team of experienced hematologists, the Department strives to become the most sought after center for the diagnosis & management of benign and malignant hematological disorders, laboratory hematological services and blood transfusion services.

Experts at the Department are experienced at treating different conditions including:

  • Anaemia
  • Sickle Cell Disease
  • Immune Deficiency Disorders
  • Thalassemia Major
  • Autoimmune Disease
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Multiple Myeloma
  • Clotting Disorders
  • Bleeding Disorders
  • Paediatric Solid Tumours (Ewings / Osteosarcomas / Neuroblastomas)

The Department always remains at the forefront of existing methods and advancements in haematology services, making for a dynamic, efficient and self-reliant center with a wide array of specialisation.

Our highly qualified multidisciplinary team is comprised of adult haematologists and paediatric haemato-oncologists that offer treatment of and research into complex blood disorders. Moreover, our constant quest to advance our knowledge and methods puts us at the extreme edge of what is possible, making for a dynamic team offering services of superlative clinical quality.

We are proud of our highest standards of patient care, which lies at the heart of all our activities. Our supportive services are second to none, making our steadfast and highly specialized center a place of contentment for patients suffering from any kind of blood disorder.

BONE MARROW TRANSPLANT

The primary aim of the Department of Bone Marrow Transplant at Fortis Memorial Research Institute is to offer world-class care for all patients who need a hematopoietic stem cell/bone marrow transplant and to improve patient outcomes through research and staff education.

The Department strives to perform cutting-edge laboratory and clinical research, specifically in the fields of immunogenetics, cellular therapy, transplant tolerance, immune reconstitution, infection control, and survivorship.

Our patients include new-borns, infants, children, adolescents and young adults who have a malignant or non-malignant life-threatening disorder that is treatable with a hematopoietic stem cell / bone marrow transplant with autologous cells or allogeneic cells.

The BMT department at FMRI is at the forefront of treatment for Leukaemia, Aplastic Anaemia, Lymphatic and Solid malignant tumours and is a leader in the field both in Israel and on an international level. BMT for non-malignant diseases, of which some are genetic and congenital and some metabolic related, is also carried out.

Our physicians have gained enormous expertise in carrying our several procedures such a autologous transplant for multiple myelomas, lymphomas, paediatric bone marrow transplant, and thalassemia transplant etc.

The department meets international criterion for BMT performance, and participates in and presents on a regular basis at international conferences on BMT and scientific publications and research on the subject.

Hematopoietic Stem Cell Transplant (HSCT Treatment) For Multiple Sclerosis At Fortis Memorial Research Institute (FMRI), Gurgaon India

Hematopoietic Stem Cell Transplant (HSCT Treatment) for Multiple Sclerosis at at Fortis Memorial Research Institute (FMRI), Gurgaon India

Multiple sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and in which an abnormal response of the body’s immune system is directed against the central nervous system (CNS), which is made up of the brain, spinal cord and optic nerves.. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease.

HSCT or Hematopioetic Stem Cell Transplant, is now a scientifically proven treatment, that has shown positive results to halt disease progression of Multiple Sclerosis. It is not a new procedure as such, as it has been used to treat cancer since the 1960’s, but it is a relatively new treatment for MS. The aim of AHSCT is to ‘reset’ the immune system to stop it from attacking the central nervous system. The procedure involves removing the harmful immune cells that attack the brain and spinal cord in MS, and then uses a person’s own stem cells to effectively re-grow the immune system. The aim is that re-booting the immune system in this way will prevent further damage in the brain and spinal cord.

The method for Autologous stem cell transplant for MS which is followed in Fortis Hospital comprises of Cyclosphosphamide and ATG. These agents act as lymphoablative drugs.

The total duration of uncomplicated stay in in India is about 24 to 28 days and the best part is that patients are managed on an inpatient basis in our world class hospital at Gurgaon near the New Delhi, the capital of India.

How does the HSCT Treatment Work?

The goal of AHSCT is to reset the patient’s immune system to stop it from attacking nerve cells in your body. During the treatment, doctors collect bone marrow stem cells from the blood and freeze them. These "haematopoietic stem cells" are at such an early stage of development that they haven't acquired the flaws that trigger MS. The faulty immune system is then destroyed using chemotherapy. The thawed-out stem cells are re-infused into the patient’s blood to reboot the immune system.

Recent studies have shown that in patient’s e with relapsing-remitting multiple sclerosis, AHSCT was linked to a significant reduction in disability on average. Eighty percent of the people treated who were followed for 4 years had no more relapses, and 87% had no worsening of their level of disability.

HSCT Medical Team At Fortis Memorial Research Hospital, India

  • Dr. Rahul Bhargava
    Dr Rahul Bhargava MD, DM (Hematology) AIIMS Head & Senior Consultant – Hematology- Oncology and Bone Marrow Transplant. know more...
  • Dr. Vikas Dua
    Dr. Praveen Gupta MD, DM (Neurology)Director & Head – Neurologyknow more...
  • Dr. Aniruddha
    Dr. Aniruddha DayamaHaematology & Bone Marrow Transplantknow more...
Close
Dr. Rahul Bhargava
Dr Rahul Bhargava in 2016 became the first Indian doctor to do and popularize stem cell transplant in multiple sclerosis. He has been credited of establishing 6 low cost centres across India namely at Sarvodaya hospital, Batra hospital, Action Balaji hospital etc.. He and his team has done 400+ transplants. He is known for his excellent outcome in stem cell transplant specially in haploidentical transplant and his vision of first integrated centre of excellence in Haematology, paediatric haematology and stem cell transplant has been full filled at Fortis Memorial Research Institute, Gurgaon (India)

Work Experience:

1995-2004 - MBBS and MD medicine Bhopal MP

2005 - 2006 - served as a senior resident in department of haematology and stem cell transplant at CMC Vellore.

2006 – 2009 AIIMS DM graduate New delhi

2011 - 2013 - established first stem cell transplant centre at Medanta the Medicity, Gurgaon and in a short span of 2 years completed 100 transplants.

2013 - 2016 he joined Artemis as Head of Haematology and did the first haploidentical transplant in Gurgaon.

Close
Aniruddha
Dr Vikas Dua is Paediatric Hemato Oncologist and bone marrow transplant specialist. Dr.Dua’s results in the field of Paediatric Haematology Oncology and BMT have been some of the best. He and his team has done 200+ paediatric transplants. He is known for his excellent outcome in stem cell transplant especially in Paediatric haploidentical transplant and he has done some of the very rare transplants which nobody else has done in India.

Work Experience:

1996 - 2002 - MBBS PGIMS Rohtak

2004 - 2007 - MD (Paediatrics) PGIMS Rohtak

2007 - 2009 - served as a senior resident in Department of Paediatrics in Rohtak and Delhi

2010 – 2012 - FNB(Paediatric Haematology Oncology) SGRH, New Delhi

2012 – 2013 - Consultant Paediatric Haematology Oncology Action CANCER Hospital, Delhi

2013 - 2014 - Fellowship In Paediatric Bone Marrow transplant, NUH Singapore

2014 - 2016 - Senior Consultant Paediatric Hemato Oncology and BMT, Artemis Hospital, Gurgaon

Close
Dr Anjila Aneja
Dr. Aniruddha Dayama in 2015 led the efforts to get NMDP, USA approval for one of the leading hospitals in Gurgaon. He and his team have popularised autologous transplants in multiple sclerosis. The team has been credited for establishing six low cost centres across North India namely at Sarvodaya hospital, Batra hospital, Action Balaji hospital etc. His expertise is in integrated haematology - benign and malignant with combined paediatric and adult services.

Work Experience

2008 - 2009 - served as a senior resident in department of haematology and stem cell transplant at CMC Vellore

2009 – 2010 - Non-DM senior resident in Haematology, AIIMS, Delhi

2011 - 2013 - DM (Clinical Haematology), AIIMS, Delhi

2013 - 2016 – Along with his team did more than 100+ transplant in Artemis hospital Gurgaon. Was responsible for affiliation with multiple donor registries including US and Germany.

About Fortis Memorial Research Institute

Fortis Memorial Research Institute is a multi-super-speciality, quaternary care hospital with an enviable international faculty, reputed clinicians, including super-sub-specialists and speciality nurses, supported by cutting-edge technology.

A premium referral hospital, it endeavors to be the ‘Mecca of Healthcare’ for Asia Pacific and beyond. Set on a spacious 11-acre campus with 1000 beds, this ‘Next Generation Hospital’ is built on a foundation of ‘Trust’ and rests on four strong pillars: Talent, Technology, Service and Infrastructure.

Enquire Now

Enquire Now

Captcha